Uptake of Tc-99m methylene diphosphonate in peritoneal metastases from breast cancer

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Distant spread from breast cancer commonly involves the bones, lungs, and liver. Metastatic involvement of the peritoneum is rare, in most cases detected only on computed tomography (CT) performed to evaluate clinical or biochemical disease progression. Several reports in the literature have described the uptake of bone-seeking radiopharmaceuticals by peritoneal metastases, the majority in the context of a primary osteogenic sarcoma, or ovarian cancer. We describe a 64-year-old woman with recurrent breast cancer presenting with contralateral axillary nodal metastases and peritoneal metastases, the latter showing avid uptake of Tc-99m methylene diphosphonate (MDP). © 2008 Lippincott Williams & Wilkins, Inc.

Cite

CITATION STYLE

APA

Wong, W. Y., & Wong, J. S. L. (2008). Uptake of Tc-99m methylene diphosphonate in peritoneal metastases from breast cancer. Clinical Nuclear Medicine, 33(3), 218–219. https://doi.org/10.1097/RLU.0b013e318162dd36

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free